117th Congress · SENATE BILLBILL

S. 3974Ending Discrimination in COVID–19 Treatments Act

A bill to prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government.

Health
Introduced Mar 31, 2022
Last action Mar 31, 2022
Pipeline · Bill → Law
Step 1
Introduced
Mar 31, 2022
Step 2
Referred
Mar 31, 2022
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate
Timeline · 2 actions
Mar 31, 2022
Introduced in Senate
Mar 31, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.